Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Hyong Kim Sells 18,600 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Hyong Kim sold 18,600 shares of the firm’s stock in a transaction on Monday, August 11th. The shares were sold at an average price of $14.54, for a total value of $270,444.00. Following the completion of the sale, the insider owned 490,767 shares of the company’s stock, valued at approximately $7,135,752.18. This trade represents a 3.65% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Alignment Healthcare Price Performance

Shares of ALHC stock opened at $14.75 on Thursday. The stock has a 50-day moving average price of $13.73 and a 200 day moving average price of $15.30. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 2.29. The firm has a market cap of $2.92 billion, a price-to-earnings ratio of -52.69 and a beta of 1.16. Alignment Healthcare, Inc. has a 12 month low of $8.24 and a 12 month high of $21.06.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 EPS for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.14. The firm had revenue of $1.02 billion during the quarter, compared to analyst estimates of $960.25 million. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%. The company’s revenue was up 49.0% on a year-over-year basis. During the same period last year, the company earned ($0.13) earnings per share. Research analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on ALHC. Barclays upgraded Alignment Healthcare from an “underweight” rating to an “equal weight” rating and raised their target price for the company from $9.00 to $13.00 in a research note on Thursday, July 31st. UBS Group raised their target price on Alignment Healthcare from $16.00 to $17.00 and gave the company a “neutral” rating in a research note on Friday, May 2nd. Stephens upgraded Alignment Healthcare to a “strong-buy” rating in a research note on Monday, June 2nd. Finally, Wall Street Zen lowered Alignment Healthcare from a “buy” rating to a “hold” rating in a research note on Sunday. Five investment analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $18.56.

Hedge Funds Weigh In On Alignment Healthcare

Institutional investors have recently modified their holdings of the stock. MCF Advisors LLC grew its position in shares of Alignment Healthcare by 87.6% during the 1st quarter. MCF Advisors LLC now owns 2,165 shares of the company’s stock worth $40,000 after buying an additional 1,011 shares during the period. Skandinaviska Enskilda Banken AB publ acquired a new position in shares of Alignment Healthcare during the 1st quarter worth about $42,000. SBI Securities Co. Ltd. grew its position in shares of Alignment Healthcare by 4,868.9% during the 2nd quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock worth $42,000 after buying an additional 2,970 shares during the period. KBC Group NV acquired a new position in shares of Alignment Healthcare during the 2nd quarter worth about $44,000. Finally, Amalgamated Bank grew its position in shares of Alignment Healthcare by 21.6% during the 1st quarter. Amalgamated Bank now owns 3,466 shares of the company’s stock worth $65,000 after buying an additional 616 shares during the period. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.